Pyridostigmine Bromide Solution
Product Images NDC 68682-307

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 68682-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

This is a medication label for Pyridostigmine Bromide, which is an oral solution used for the treatment of myasthenia gravis (a neuromuscular disorder). Each 5 mL of the solution contains 60 mg of the medicine, and the dosage has to be adjusted based on individual needs. The medication has to be stored at room temperature in a light-resistant container and should be kept out of the reach of children. The given NDC number is 6846230705.*

FDA Label Image

Mestinon-01.jpg (Mestinon 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.